Medical/Pharmaceuticals
I-Mab Announces Upcoming Participation at May Conferences
SHANGHAI and GAITHERSBURG, Md., April 29, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in May. ...
2021-04-29 20:00
3236
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A geneti...
2021-04-29 19:47
1996
2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees
FLORENCE, Italy, April 29, 2021 /PRNewswire/ -- PQE Group
2021-04-29 18:18
904
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland
BASEL, Switzerland, April 29, 2021 /PRNewswire/ -- Hilco Industrial Acquisitions, anAmsterdam-based Industrial Asset Disposition and Acquisition Company, acquired all Machinery & Equipment from theSwiss-based CMO Legacy Pharmaceuticals. After several years of expansion, the Swiss company was forc...
2021-04-29 13:04
1627
Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment
SHANGHAI and HONG KONG, April 29, 2021 /PRNewswire/ -- With the official release and implementation ofthe Overall Plan for the Construction of Hainan Free Trade Port, patient can now access global innovative medicines in mainland China. Recently, the global first-in-class selective inhibitor of n...
2021-04-29 08:34
2876
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib)
SUZHOU, China, April 29, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer to evaluate the efficacy and safety of KN046 in combination with Inlyta® (axitinib) for the first-line treatment ...
2021-04-29 08:00
4472
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
SAN FRANCISCO and SUZHOU, China, April 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...
2021-04-29 08:00
4432
Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services
HERZLIYA, Israel, April 28, 2021 /PRNewswire/ -- Essence Group
2021-04-29 07:01
1611
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test"
GUANGZHOU, China, April 28, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, together with renowned thoracic experts from 14 top-tier hospitals inChina, jointly published a clinical research paper entitled "Accurate Diagnosis of Pulmonary...
2021-04-28 21:00
1506
CROs dMed and Clinipace Merge to Accelerate Customer Success
SHANGHAI and MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ -- dMed Global, a full-service Clinical Contract Research Organization (CRO) based inShanghai, China, and Clinipace Incorporated, a full-service Clinical CRO with headquarters inNorth Carolina, USA, announced today that the two companies...
2021-04-28 20:00
2722
I-Mab Filed 2020 Annual Report on Form 20-F
SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...
2021-04-28 20:00
1520
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2
- Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2 - Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed - Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cornea and External Disease HEIDELBERG, Germany and C...
2021-04-28 20:00
1388
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
PHILADELPHIA, April 28, 2021 /PRNewswire/ -- ERT, a global leader in clinical endpoint data solutions, today announced the close of its merger withBioclinica , a technological and scientific leader in clinical imaging. This combination creates the global leader in clinical trial endpoint technolog...
2021-04-28 19:59
2260
Turn Biotechnologies completes latest round of funding
Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn MOUNTAIN VIEW, Calif., April 28, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related conditions, today announced that it has closed its latest...
2021-04-28 19:50
2394
Samsung Biologics Reports First Quarter 2021 Financial Results
* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...
2021-04-28 16:37
4338
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute
BASEL, Switzerland, April 28, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On...
2021-04-28 15:00
1371
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services
KAWAGOE, Japan, April 28, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company ("Chuo Unyu") to carry out inspection, labeling, pac...
2021-04-28 14:00
994
Genesis MedTech to Introduce Revolutionary Laparoscopic Technology to China and Singapore
SINGAPORE, April 28, 2021 /PRNewswire/ -- Genesis MedTech has entered a strategic distribution agreement with LivsMed, a medical device company that brings ground-breaking technology to minimally invasive surgery, for the sales and distribution of the ArtiSential™ line of products for the Chin...
2021-04-28 10:01
3847
HMI Group and Siemens Healthineers enters into strategic partnership to advance healthcare delivery in Southeast Asia
* This 5-year partnership valued over SGD 32 million, is first-of-its-kind strategic partnership for Siemens Healthineers in the region. * It focuses on upgrading HMI Group's healthcare facilities, anchoring on digitalization and enhancing local talent pool. * It includes further developme...
2021-04-28 08:05
2655
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
PALO ALTO, Calif., April 28, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement withAustralia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further stre...
2021-04-28 04:15
2073
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2965
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2963
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2847